-
1
-
-
49349107361
-
-
World Health Organization, Available online, accessed on 5 August
-
World Health Organization. The Top 10 Causes of Death. Available online: http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed on 5 August 2013).
-
(2013)
The Top 10 Causes of Death
-
-
-
2
-
-
77955435925
-
US cost burden of ischemic stroke: A systematic literature review
-
Demaerschalk, B.M.; Hwang, H.M.; Leung, G. US cost burden of ischemic stroke: A systematic literature review. Am. J. Manag. Care 2010, 16, 525-533.
-
(2010)
Am. J. Manag. Care
, vol.16
, pp. 525-533
-
-
Demaerschalk, B.M.1
Hwang, H.M.2
Leung, G.3
-
3
-
-
79451474588
-
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association
-
Furie, K.L.; Kasner, S.E.; Adams, R.J.; Albers, G.W.; Bush, R.L.; Fagan, S.C.; Halperin, J.L.; Johnston, S.C.; Katzan, I.; Kernan, W.N. et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011, 42, 227-276.
-
(2011)
Stroke
, vol.42
, pp. 227-276
-
-
Furie, K.L.1
Kasner, S.E.2
Adams, R.J.3
Albers, G.W.4
Bush, R.L.5
Fagan, S.C.6
Halperin, J.L.7
Johnston, S.C.8
Katzan, I.9
Kernan, W.N.10
-
4
-
-
0031178776
-
American heart association prevention conference. IV. Prevention and rehabilitation of stroke. Risk factors
-
Sacco, R.L.; Benjamin, E.J.; Broderick, J.P.; Dyken, M.; Easton, J.D.; Feinberg, W.M.; Goldstein, L.B.; Gorelick, P.B.; Howard, G.; Kittner, S.J. et al. American heart association prevention conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997, 28, 1507-1517.
-
(1997)
Stroke
, vol.28
, pp. 1507-1517
-
-
Sacco, R.L.1
Benjamin, E.J.2
Broderick, J.P.3
Dyken, M.4
Easton, J.D.5
Feinberg, W.M.6
Goldstein, L.B.7
Gorelick, P.B.8
Howard, G.9
Kittner, S.J.10
-
5
-
-
77957270368
-
The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents
-
Grossin, N.; Boulanger, E.; Wautier, M.P.; Wautier, J.L. The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents. Clin. Hemorheol. Microcirc. 2010, 45, 143-153.
-
(2010)
Clin. Hemorheol. Microcirc
, vol.45
, pp. 143-153
-
-
Grossin, N.1
Boulanger, E.2
Wautier, M.P.3
Wautier, J.L.4
-
6
-
-
0023950461
-
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
-
Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988, 318, 1315-1321.
-
(1988)
N. Engl. J. Med
, vol.318
, pp. 1315-1321
-
-
Brownlee, M.1
Cerami, A.2
Vlassara, H.3
-
7
-
-
0027956982
-
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
-
Bucala, R.; Makita, Z.; Vega, G.; Grundy, S.; Koschinsky, T.; Cerami, A.; Vlassara, H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA 1994, 91, 9441-9445.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 9441-9445
-
-
Bucala, R.1
Makita, Z.2
Vega, G.3
Grundy, S.4
Koschinsky, T.5
Cerami, A.6
Vlassara, H.7
-
8
-
-
0026784628
-
Glucose and diabetic vascular disease
-
Ruderman, N.B.; Williamson, J.R.; Brownlee, M. Glucose and diabetic vascular disease. FASEB J. 1992, 6, 2905-2914.
-
(1992)
FASEB J
, vol.6
, pp. 2905-2914
-
-
Ruderman, N.B.1
Williamson, J.R.2
Brownlee, M.3
-
9
-
-
0026659883
-
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
-
Neeper, M.; Schmidt, A.M.; Brett, J.; Yan, S.D.; Wang, F.; Pan, Y.C.; Elliston, K.; Stern, D.; Shaw, A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267, 14998-15004.
-
(1992)
J. Biol. Chem
, vol.267
, pp. 14998-15004
-
-
Neeper, M.1
Schmidt, A.M.2
Brett, J.3
Yan, S.D.4
Wang, F.5
Pan, Y.C.6
Elliston, K.7
Stern, D.8
Shaw, A.9
-
10
-
-
0026650438
-
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface
-
Schmidt, A.M.; Vianna, M.; Gerlach, M.; Brett, J.; Ryan, J.; Kao, J.; Esposito, C.; Hegarty, H.; Hurley, W.; Clauss, M. et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267, 14987-14997.
-
(1992)
J. Biol. Chem
, vol.267
, pp. 14987-14997
-
-
Schmidt, A.M.1
Vianna, M.2
Gerlach, M.3
Brett, J.4
Ryan, J.5
Kao, J.6
Esposito, C.7
Hegarty, H.8
Hurley, W.9
Clauss, M.10
-
11
-
-
10744229528
-
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
-
Chavakis, T.; Bierhaus, A.; Al-Fakhri, N.; Schneider, D.; Witte, S.; Linn, T.; Nagashima, M.; Morser, J.; Arnold, B.; Preissner, K.T. et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment. J. Exp. Med. 2003, 198, 1507-1515.
-
(2003)
J. Exp. Med
, vol.198
, pp. 1507-1515
-
-
Chavakis, T.1
Bierhaus, A.2
Al-Fakhri, N.3
Schneider, D.4
Witte, S.5
Linn, T.6
Nagashima, M.7
Morser, J.8
Arnold, B.9
Preissner, K.T.10
-
12
-
-
35248813974
-
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein
-
Marsche, G.; Weigle, B.; Sattler, W.; Malle, E. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein. FASEB J. 2007, 21, 3075-3082.
-
(2007)
FASEB J
, vol.21
, pp. 3075-3082
-
-
Marsche, G.1
Weigle, B.2
Sattler, W.3
Malle, E.4
-
13
-
-
51749105625
-
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
-
Katakami, N.; Matsuhisa, M.; Kaneto, H.; Matsuoka, T.A.; Sakamoto, K.; Yasuda, T.; Yamasaki, Y. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients. Diabetes Vasc. Dis. Res. 2008, 5, 190-197.
-
(2008)
Diabetes Vasc. Dis. Res
, vol.5
, pp. 190-197
-
-
Katakami, N.1
Matsuhisa, M.2
Kaneto, H.3
Matsuoka, T.A.4
Sakamoto, K.5
Yasuda, T.6
Yamasaki, Y.7
-
14
-
-
0344286498
-
Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
-
Schmidt, A.M.; Yan, S.D.; Wautier, J.L.; Stern, D. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 1999, 84, 489-497.
-
(1999)
Circ. Res
, vol.84
, pp. 489-497
-
-
Schmidt, A.M.1
Yan, S.D.2
Wautier, J.L.3
Stern, D.4
-
15
-
-
0024469223
-
Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions
-
Mosevitsky, M.I.; Novitskaya, V.A.; Iogannsen, M.G.; Zabezhinsky, M.A. Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur. J. Biochem. 1989, 185, 303-310.
-
(1989)
Eur. J. Biochem
, vol.185
, pp. 303-310
-
-
Mosevitsky, M.I.1
Novitskaya, V.A.2
Iogannsen, M.G.3
Zabezhinsky, M.A.4
-
16
-
-
0030473893
-
Characterization of a high mobility group 1/2 homolog in yeast
-
Lu, J.; Kobayashi, R.; Brill, S.J. Characterization of a high mobility group 1/2 homolog in yeast. J. Biol. Chem. 1996, 271, 33678-33685.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 33678-33685
-
-
Lu, J.1
Kobayashi, R.2
Brill, S.J.3
-
17
-
-
33747751590
-
Alarmin(g) news about danger: Workshop on innate danger signals and HMGB1
-
Harris, H.E.; Raucci, A. Alarmin(g) news about danger: Workshop on innate danger signals and HMGB1. EMBO Rep. 2006, 7, 774-778.
-
(2006)
EMBO Rep
, vol.7
, pp. 774-778
-
-
Harris, H.E.1
Raucci, A.2
-
18
-
-
10844281923
-
Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1
-
Mullins, G.E.; Sunden-Cullberg, J.; Johansson, A.S.; Rouhiainen, A.; Erlandsson-Harris, H.; Yang, H.; Tracey, K.J.; Rauvala, H.; Palmblad, J.; Andersson, J. et al. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand. J. Immunol. 2004, 60, 566-573.
-
(2004)
Scand. J. Immunol
, vol.60
, pp. 566-573
-
-
Mullins, G.E.1
Sunden-Cullberg, J.2
Johansson, A.S.3
Rouhiainen, A.4
Erlandsson-Harris, H.5
Yang, H.6
Tracey, K.J.7
Rauvala, H.8
Palmblad, J.9
Andersson, J.10
-
19
-
-
1542380035
-
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
-
Park, J.S.; Svetkauskaite, D.; He, Q.; Kim, J.Y.; Strassheim, D.; Ishizaka, A.; Abraham, E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279, 7370-7377.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 7370-7377
-
-
Park, J.S.1
Svetkauskaite, D.2
He, Q.3
Kim, J.Y.4
Strassheim, D.5
Ishizaka, A.6
Abraham, E.7
-
20
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi, P.; Misteli, T.; Bianchi, M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418, 191-195.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
21
-
-
0034682315
-
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
-
Taguchi, A.; Blood, D.C.; del Toro, G.; Canet, A.; Lee, D.C.; Qu, W.; Tanji, N.; Lu, Y.; Lalla, E.; Fu, C. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405, 354-360.
-
(2000)
Nature
, vol.405
, pp. 354-360
-
-
Taguchi, A.1
Blood, D.C.2
del Toro, G.3
Canet, A.4
Lee, D.C.5
Qu, W.6
Tanji, N.7
Lu, Y.8
Lalla, E.9
Fu, C.10
-
22
-
-
0037386810
-
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
-
Taniguchi, N.; Kawahara, K.; Yone, K.; Hashiguchi, T.; Yamakuchi, M.; Goto, M.; Inoue, K.; Yamada, S.; Ijiri, K.; Matsunaga, S. et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003, 48, 971-981.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 971-981
-
-
Taniguchi, N.1
Kawahara, K.2
Yone, K.3
Hashiguchi, T.4
Yamakuchi, M.5
Goto, M.6
Inoue, K.7
Yamada, S.8
Ijiri, K.9
Matsunaga, S.10
-
23
-
-
0033538467
-
HMG-1 as a late mediator of endotoxin lethality in mice
-
Wang, H.; Bloom, O.; Zhang, M.; Vishnubhakat, J.M.; Ombrellino, M.; Che, J.; Frazier, A.; Yang, H.; Ivanova, S.; Borovikova, L. et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285, 248-251.
-
(1999)
Science
, vol.285
, pp. 248-251
-
-
Wang, H.1
Bloom, O.2
Zhang, M.3
Vishnubhakat, J.M.4
Ombrellino, M.5
Che, J.6
Frazier, A.7
Yang, H.8
Ivanova, S.9
Borovikova, L.10
-
24
-
-
0032816123
-
Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes
-
Wang, H.; Vishnubhakat, J.M.; Bloom, O.; Zhang, M.; Ombrellino, M.; Sama, A.; Tracey, K.J. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999, 126, 389-392.
-
(1999)
Surgery
, vol.126
, pp. 389-392
-
-
Wang, H.1
Vishnubhakat, J.M.2
Bloom, O.3
Zhang, M.4
Ombrellino, M.5
Sama, A.6
Tracey, K.J.7
-
25
-
-
33845951211
-
DAMPs, PAMPs and alarmins: All we need to know about danger
-
Bianchi, M.E. DAMPs, PAMPs and alarmins: All we need to know about danger. J. Leukoc. Biol. 2007, 81, 1-5.
-
(2007)
J. Leukoc. Biol
, vol.81
, pp. 1-5
-
-
Bianchi, M.E.1
-
26
-
-
20544442905
-
Alarmins: Chemotactic activators of immune responses
-
Oppenheim, J.J.; Yang, D. Alarmins: Chemotactic activators of immune responses. Curr. Opin. Immunol. 2005, 17, 359-365.
-
(2005)
Curr. Opin. Immunol
, vol.17
, pp. 359-365
-
-
Oppenheim, J.J.1
Yang, D.2
-
27
-
-
20644449041
-
HMGB1: Guiding immunity from within
-
Dumitriu, I.E.; Baruah, P.; Manfredi, A.A.; Bianchi, M.E.; Rovere-Querini, P. HMGB1: Guiding immunity from within. Trends. Immunol. 2005, 26, 381-387.
-
(2005)
Trends. Immunol
, vol.26
, pp. 381-387
-
-
Dumitriu, I.E.1
Baruah, P.2
Manfredi, A.A.3
Bianchi, M.E.4
Rovere-Querini, P.5
-
28
-
-
33745628553
-
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia
-
Goldstein, R.S.; Gallowitsch-Puerta, M.; Yang, L.; Rosas-Ballina, M.; Huston, J.M.; Czura, C.J.; Lee, D.C.; Ward, M.F.; Bruchfeld, A.N.; Wang, H. et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006, 25, 571-574.
-
(2006)
Shock
, vol.25
, pp. 571-574
-
-
Goldstein, R.S.1
Gallowitsch-Puerta, M.2
Yang, L.3
Rosas-Ballina, M.4
Huston, J.M.5
Czura, C.J.6
Lee, D.C.7
Ward, M.F.8
Bruchfeld, A.N.9
Wang, H.10
-
29
-
-
77952390069
-
High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis
-
Kawabata, H.; Setoguchi, T.; Yone, K.; Souda, M.; Yoshida, H.; Kawahara, K.; Maruyama, I.; Komiya, S. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine 2010, 35, 1109-1115.
-
(2010)
Spine
, vol.35
, pp. 1109-1115
-
-
Kawabata, H.1
Setoguchi, T.2
Yone, K.3
Souda, M.4
Yoshida, H.5
Kawahara, K.6
Maruyama, I.7
Komiya, S.8
-
30
-
-
77955784283
-
HMGB1: A new marker for estimation of the postmortem interval
-
Kikuchi, K.; Kawahara, K.I.; Biswas, K.K.; Ito, T.; Tancharoen, S.; Shiomi, N.; Koda, Y.; Matsuda, F.; Morimoto, Y.; Oyama, Y. et al. HMGB1: A new marker for estimation of the postmortem interval. Exp. Ther. Med. 2010, 1, 109-111.
-
(2010)
Exp. Ther. Med
, vol.1
, pp. 109-111
-
-
Kikuchi, K.1
Kawahara, K.I.2
Biswas, K.K.3
Ito, T.4
Tancharoen, S.5
Shiomi, N.6
Koda, Y.7
Matsuda, F.8
Morimoto, Y.9
Oyama, Y.10
-
31
-
-
79960267925
-
HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development
-
Kikuchi, K.; Uchikado, H.; Miura, N.; Morimoto, Y.; Ito, T.; Tancharoen, S.; Miyata, K.; Sakamoto, R.; Kikuchi, C.; Iida, N. et al. HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development. Exp. Ther. Med. 2011, 2, 767-770.
-
(2011)
Exp. Ther. Med
, vol.2
, pp. 767-770
-
-
Kikuchi, K.1
Uchikado, H.2
Miura, N.3
Morimoto, Y.4
Ito, T.5
Tancharoen, S.6
Miyata, K.7
Sakamoto, R.8
Kikuchi, C.9
Iida, N.10
-
32
-
-
70350647307
-
Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis
-
Lindstrom, O.; Tukiainen, E.; Kylanpaa, L.; Mentula, P.; Rouhiainen, A.; Puolakkainen, P.; Rauvala, H.; Repo, H. Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis. Pancreas 2009, 38, e215-e220.
-
(2009)
Pancreas
, vol.38
-
-
Lindstrom, O.1
Tukiainen, E.2
Kylanpaa, L.3
Mentula, P.4
Rouhiainen, A.5
Puolakkainen, P.6
Rauvala, H.7
Repo, H.8
-
33
-
-
17144376810
-
High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal
-
Lotze, M.T.; Tracey, K.J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5, 331-342.
-
(2005)
Nat. Rev. Immunol
, vol.5
, pp. 331-342
-
-
Lotze, M.T.1
Tracey, K.J.2
-
34
-
-
38349185374
-
Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1
-
Morimoto, Y.; Kawahara, K.I.; Tancharoen, S.; Kikuchi, K.; Matsuyama, T.; Hashiguchi, T.; Izumi, Y.; Maruyama, I. Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. J. Periodontal Res. 2008, 43, 76-83.
-
(2008)
J. Periodontal Res
, vol.43
, pp. 76-83
-
-
Morimoto, Y.1
Kawahara, K.I.2
Tancharoen, S.3
Kikuchi, K.4
Matsuyama, T.5
Hashiguchi, T.6
Izumi, Y.7
Maruyama, I.8
-
35
-
-
84865975819
-
Periodontal disease and type 2 diabetes mellitus: Is the HMGB1-RAGE axis the missing link?
-
Morimoto-Yamashita, Y.; Ito, T.; Kawahara, K.; Kikuchi, K.; Tatsuyama-Nagayama, S.; Kawakami-Morizono, Y.; Fijisawa, M.; Miyashita, K.; Emoto, M.; Torii, M. et al. Periodontal disease and type 2 diabetes mellitus: Is the HMGB1-RAGE axis the missing link? Med. Hypotheses 2012, 79, 452-455.
-
(2012)
Med. Hypotheses
, vol.79
, pp. 452-455
-
-
Morimoto-Yamashita, Y.1
Ito, T.2
Kawahara, K.3
Kikuchi, K.4
Tatsuyama-Nagayama, S.5
Kawakami-Morizono, Y.6
Fijisawa, M.7
Miyashita, K.8
Emoto, M.9
Torii, M.10
-
36
-
-
78649535273
-
Protective effect of high-mobility group box 1 blockade on acute liver failure in rats
-
Takano, K.; Shinoda, M.; Tanabe, M.; Miyasho, T.; Yamada, S.; Ono, S.; Masugi, Y.; Suda, K.; Fukunaga, K.; Hayashida, T. et al. Protective effect of high-mobility group box 1 blockade on acute liver failure in rats. Shock 2010, 34, 573-579.
-
(2010)
Shock
, vol.34
, pp. 573-579
-
-
Takano, K.1
Shinoda, M.2
Tanabe, M.3
Miyasho, T.4
Yamada, S.5
Ono, S.6
Masugi, Y.7
Suda, K.8
Fukunaga, K.9
Hayashida, T.10
-
37
-
-
33745461107
-
High-mobility group box 1 (HMGB1) protein: Friend and foe
-
Ulloa, L.; Messmer, D. High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev. 2006, 17, 189-201.
-
(2006)
Cytokine Growth Factor Rev
, vol.17
, pp. 189-201
-
-
Ulloa, L.1
Messmer, D.2
-
38
-
-
40949158889
-
Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia
-
Van Zoelen, M.A.; Ishizaka, A.; Wolthuls, E.K.; Choi, G.; van der Poll, T.; Schultz, M.J. Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 2008, 29, 441-445.
-
(2008)
Shock
, vol.29
, pp. 441-445
-
-
van Zoelen, M.A.1
Ishizaka, A.2
Wolthuls, E.K.3
Choi, G.4
van der Poll, T.5
Schultz, M.J.6
-
39
-
-
59449099249
-
Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling
-
Kohno, T.; Anzai, T.; Naito, K.; Miyasho, T.; Okamoto, M.; Yokota, H.; Yamada, S.; Maekawa, Y.; Takahashi, T.; Yoshikawa, T. et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc. Res. 2009, 81, 565-573.
-
(2009)
Cardiovasc. Res
, vol.81
, pp. 565-573
-
-
Kohno, T.1
Anzai, T.2
Naito, K.3
Miyasho, T.4
Okamoto, M.5
Yokota, H.6
Yamada, S.7
Maekawa, Y.8
Takahashi, T.9
Yoshikawa, T.10
-
40
-
-
34447108927
-
Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer
-
Maeda, S.; Hikiba, Y.; Shibata, W.; Ohmae, T.; Yanai, A.; Ogura, K.; Yamada, S.; Omata, M. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem. Biophys. Res. Commun. 2007, 360, 394-400.
-
(2007)
Biochem. Biophys. Res. Commun
, vol.360
, pp. 394-400
-
-
Maeda, S.1
Hikiba, Y.2
Shibata, W.3
Ohmae, T.4
Yanai, A.5
Ogura, K.6
Yamada, S.7
Omata, M.8
-
41
-
-
33845989093
-
Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis
-
Sawa, H.; Ueda, T.; Takeyama, Y.; Yasuda, T.; Shinzeki, M.; Nakajima, T.; Kuroda, Y. Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J. Gastroenterol. 2006, 12, 7666-7670.
-
(2006)
World J. Gastroenterol
, vol.12
, pp. 7666-7670
-
-
Sawa, H.1
Ueda, T.2
Takeyama, Y.3
Yasuda, T.4
Shinzeki, M.5
Nakajima, T.6
Kuroda, Y.7
-
42
-
-
0037388395
-
High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis
-
Ulloa, L.; Batliwalla, F.M.; Andersson, U.; Gregersen, P.K.; Tracey, K.J. High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum. 2003, 48, 876-881.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 876-881
-
-
Ulloa, L.1
Batliwalla, F.M.2
Andersson, U.3
Gregersen, P.K.4
Tracey, K.J.5
-
43
-
-
13944268827
-
The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/ reperfusion injury in mice
-
Watanabe, T.; Kubota, S.; Nagaya, M.; Ozaki, S.; Nagafuchi, H.; Akashi, K.; Taira, Y.; Tsukikawa, S.; Oowada, S.; Nakano, S. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/ reperfusion injury in mice. J. Surg. Res. 2005, 124, 59-66.
-
(2005)
J. Surg. Res
, vol.124
, pp. 59-66
-
-
Watanabe, T.1
Kubota, S.2
Nagaya, M.3
Ozaki, S.4
Nagafuchi, H.5
Akashi, K.6
Taira, Y.7
Tsukikawa, S.8
Oowada, S.9
Nakano, S.10
-
44
-
-
33749019109
-
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock
-
Yang, R.; Harada, T.; Mollen, K.P.; Prince, J.M.; Levy, R.M.; Englert, J.A.; Gallowitsch-Puerta, M.; Yang, L.; Yang, H.; Tracey, K.J. et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 2006, 12, 105-114.
-
(2006)
Mol. Med
, vol.12
, pp. 105-114
-
-
Yang, R.1
Harada, T.2
Mollen, K.P.3
Prince, J.M.4
Levy, R.M.5
Englert, J.A.6
Gallowitsch-Puerta, M.7
Yang, L.8
Yang, H.9
Tracey, K.J.10
-
45
-
-
77955777876
-
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion
-
Wu, X.; Kihara, T.; Hongo, H.; Akaike, A.; Niidome, T.; Sugimoto, H. Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. Br. J. Pharmacol. 2010, 161, 33-50.
-
(2010)
Br. J. Pharmacol
, vol.161
, pp. 33-50
-
-
Wu, X.1
Kihara, T.2
Hongo, H.3
Akaike, A.4
Niidome, T.5
Sugimoto, H.6
-
46
-
-
12844288089
-
Development of an ischemic tolerance model in a PC12 cell line
-
Hillion, J.A.; Takahashi, K.; Maric, D.; Ruetzler, C.; Barker, J.L.; Hallenbeck, J.M. Development of an ischemic tolerance model in a PC12 cell line. J. Cereb. Blood Flow Metab. 2005, 25, 154-162.
-
(2005)
J. Cereb. Blood Flow Metab
, vol.25
, pp. 154-162
-
-
Hillion, J.A.1
Takahashi, K.2
Maric, D.3
Ruetzler, C.4
Barker, J.L.5
Hallenbeck, J.M.6
-
47
-
-
0017264890
-
Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans
-
Yamori, Y.; Horie, R.; Handa, H.; Sato, M.; Fukase, M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976, 7, 46-53.
-
(1976)
Stroke
, vol.7
, pp. 46-53
-
-
Yamori, Y.1
Horie, R.2
Handa, H.3
Sato, M.4
Fukase, M.5
-
48
-
-
0030802223
-
Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP)
-
Katayama, Y.; Katsumata, T.; Muramatsu, H.; Usuda, K.; Obo, R.; Terashi, A. Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain Res. 1997, 761, 300-305.
-
(1997)
Brain Res
, vol.761
, pp. 300-305
-
-
Katayama, Y.1
Katsumata, T.2
Muramatsu, H.3
Usuda, K.4
Obo, R.5
Terashi, A.6
-
49
-
-
80052044652
-
Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models
-
Thoene-Reineke, C.; Rumschussel, K.; Schmerbach, K.; Krikov, M.; Wengenmayer, C.; Godes, M.; Mueller, S.; Villringer, A.; Steckelings, U.; Namsolleck, P. et al. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS One 2011, 6, e23646:1-e23646:10.
-
(2011)
PLoS One
, vol.6
-
-
Thoene-Reineke, C.1
Rumschussel, K.2
Schmerbach, K.3
Krikov, M.4
Wengenmayer, C.5
Godes, M.6
Mueller, S.7
Villringer, A.8
Steckelings, U.9
Namsolleck, P.10
-
50
-
-
1342346788
-
Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats
-
Shimamura, T.; Masui, M.; Torii, M.; Nakajima, M. Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 2004, 26, 27-42.
-
(2004)
Clin. Exp. Hypertens
, vol.26
, pp. 27-42
-
-
Shimamura, T.1
Masui, M.2
Torii, M.3
Nakajima, M.4
-
51
-
-
0030800377
-
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats
-
Inada, Y.; Wada, T.; Ojima, M.; Sanada, T.; Shibouta, Y.; Kanagawa, R.; Ishimura, Y.; Fujisawa, Y.; Nishikawa, K. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 1997, 19, 1079-1099.
-
(1997)
Clin. Exp. Hypertens
, vol.19
, pp. 1079-1099
-
-
Inada, Y.1
Wada, T.2
Ojima, M.3
Sanada, T.4
Shibouta, Y.5
Kanagawa, R.6
Ishimura, Y.7
Fujisawa, Y.8
Nishikawa, K.9
-
52
-
-
2442655323
-
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning
-
Rattiner, L.M.; Davis, M.; French, C.T.; Ressler, K.J. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J. Neurosci. 2004, 24, 4796-4806.
-
(2004)
J. Neurosci
, vol.24
, pp. 4796-4806
-
-
Rattiner, L.M.1
Davis, M.2
French, C.T.3
Ressler, K.J.4
-
53
-
-
0028923784
-
A BDNF autocrine loop in adult sensory neurons prevents cell death
-
Acheson, A.; Conover, J.C.; Fandl, J.P.; DeChiara, T.M.; Russell, M.; Thadani, A.; Squinto, S.P.; Yancopoulos, G.D.; Lindsay, R.M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995, 374, 450-453.
-
(1995)
Nature
, vol.374
, pp. 450-453
-
-
Acheson, A.1
Conover, J.C.2
Fandl, J.P.3
Dechiara, T.M.4
Russell, M.5
Thadani, A.6
Squinto, S.P.7
Yancopoulos, G.D.8
Lindsay, R.M.9
-
54
-
-
0034927081
-
Neurotrophins: Roles in neuronal development and function
-
Huang, E.J.; Reichardt, L.F. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24, 677-736.
-
(2001)
Annu. Rev. Neurosci
, vol.24
, pp. 677-736
-
-
Huang, E.J.1
Reichardt, L.F.2
-
55
-
-
2342545917
-
Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat
-
Lou, M.; Blume, A.; Zhao, Y.; Gohlke, P.; Deuschl, G.; Herdegen, T.; Culman, J. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J. Cereb. Blood Flow Metab. 2004, 24, 536-547.
-
(2004)
J. Cereb. Blood Flow Metab
, vol.24
, pp. 536-547
-
-
Lou, M.1
Blume, A.2
Zhao, Y.3
Gohlke, P.4
Deuschl, G.5
Herdegen, T.6
Culman, J.7
-
56
-
-
79957885653
-
Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT(1) receptor blockade
-
Tsukuda, K.; Mogi, M.; Iwanami, J.; Min, L.J.; Jing, F.; Oshima, K.; Horiuchi, M. Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT(1) receptor blockade. Biochem. Biophys. Res. Commun. 2011, 409, 275-279.
-
(2011)
Biochem. Biophys. Res. Commun
, vol.409
, pp. 275-279
-
-
Tsukuda, K.1
Mogi, M.2
Iwanami, J.3
Min, L.J.4
Jing, F.5
Oshima, K.6
Horiuchi, M.7
-
57
-
-
1842473651
-
The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats
-
Engelhorn, T.; Goerike, S.; Doerfler, A.; Okorn, C.; Forsting, M.; Heusch, G.; Schulz, R. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2004, 24, 467-474.
-
(2004)
J. Cereb. Blood Flow Metab
, vol.24
, pp. 467-474
-
-
Engelhorn, T.1
Goerike, S.2
Doerfler, A.3
Okorn, C.4
Forsting, M.5
Heusch, G.6
Schulz, R.7
-
58
-
-
39849108925
-
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats
-
Krikov, M.; Thone-Reineke, C.; Muller, S.; Villringer, A.; Unger, T. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens. 2008, 26, 544-552.
-
(2008)
J. Hypertens
, vol.26
, pp. 544-552
-
-
Krikov, M.1
Thone-Reineke, C.2
Muller, S.3
Villringer, A.4
Unger, T.5
-
59
-
-
58949103804
-
Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis
-
Dang, A.B.; Tay, B.K.; Kim, H.T.; Nauth, A.; Alfonso-Jaume, M.A.; Lovett, D.H. Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis. Spine 2008, 33, E576-E579.
-
(2008)
Spine
, vol.33
-
-
Dang, A.B.1
Tay, B.K.2
Kim, H.T.3
Nauth, A.4
Alfonso-Jaume, M.A.5
Lovett, D.H.6
-
60
-
-
79955740049
-
Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusion
-
Guan, W.; Kozak, A.; El-Remessy, A.B.; Johnson, M.H.; Pillai, B.A.; Fagan, S.C. Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusion. Transl. Stroke Res. 2011, 2, 179-185.
-
(2011)
Transl. Stroke Res
, vol.2
, pp. 179-185
-
-
Guan, W.1
Kozak, A.2
El-Remessy, A.B.3
Johnson, M.H.4
Pillai, B.A.5
Fagan, S.C.6
-
61
-
-
33644818304
-
1,026 experimental treatments in acute stroke
-
O'Collins, V.E.; Macleod, M.R.; Donnan, G.A.; Horky, L.L.; van der Worp, B.H.; Howells, D.W. 1,026 experimental treatments in acute stroke. Ann. Neurol. 2006, 59, 467-477.
-
(2006)
Ann. Neurol
, vol.59
, pp. 467-477
-
-
O'Collins, V.E.1
Macleod, M.R.2
Donnan, G.A.3
Horky, L.L.4
van der Worp, B.H.5
Howells, D.W.6
-
62
-
-
52249116778
-
Telmisartan to prevent recurrent stroke and cardiovascular events
-
Yusuf, S.; Diener, H.C.; Sacco, R.L.; Cotton, D.; Ounpuu, S.; Lawton, W.A.; Palesch, Y.; Martin, R.H.; Albers, G.W.; Bath, P. et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med. 2008, 359, 1225-1237.
-
(2008)
N. Engl. J. Med
, vol.359
, pp. 1225-1237
-
-
Yusuf, S.1
Diener, H.C.2
Sacco, R.L.3
Cotton, D.4
Ounpuu, S.5
Lawton, W.A.6
Palesch, Y.7
Martin, R.H.8
Albers, G.W.9
Bath, P.10
-
63
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
Yusuf, S.; Teo, K.K.; Pogue, J.; Dyal, L.; Copland, I.; Schumacher, H.; Dagenais, G.; Sleight, P.; Anderson, C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 2008, 358, 1547-1559.
-
(2008)
N. Engl. J. Med
, vol.358
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
Dyal, L.4
Copland, I.5
Schumacher, H.6
Dagenais, G.7
Sleight, P.8
Anderson, C.9
-
64
-
-
53049109468
-
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial
-
Yusuf, S.; Teo, K.; Anderson, C.; Pogue, J.; Dyal, L.; Copland, I.; Schumacher, H.; Dagenais, G.; Sleight, P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet 2008, 372, 1174-1183.
-
(2008)
Lancet
, vol.372
, pp. 1174-1183
-
-
Yusuf, S.1
Teo, K.2
Anderson, C.3
Pogue, J.4
Dyal, L.5
Copland, I.6
Schumacher, H.7
Dagenais, G.8
Sleight, P.9
-
65
-
-
79952398794
-
Irbesartan in patients with atrial fibrillation
-
Yusuf, S.; Healey, J.S.; Pogue, J.; Chrolavicius, S.; Flather, M.; Hart, R.G.; Hohnloser, S.H.; Joyner, C.D.; Pfeffer, M.A.; Connolly, S.J. Irbesartan in patients with atrial fibrillation. N. Engl. J. Med. 2011 364, 928-938.
-
(2011)
N. Engl. J. Med
, vol.364
, pp. 928-938
-
-
Yusuf, S.1
Healey, J.S.2
Pogue, J.3
Chrolavicius, S.4
Flather, M.5
Hart, R.G.6
Hohnloser, S.H.7
Joyner, C.D.8
Pfeffer, M.A.9
Connolly, S.J.10
-
66
-
-
84856147735
-
A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan
-
Beer, C.; Blacker, D.; Bynevelt, M.; Hankey, G.J.; Puddey, I.B. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan. Int. J. Stroke 2012, 7, 104-111.
-
(2012)
Int. J. Stroke
, vol.7
, pp. 104-111
-
-
Beer, C.1
Blacker, D.2
Bynevelt, M.3
Hankey, G.J.4
Puddey, I.B.5
-
67
-
-
0037534905
-
The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial
-
Lithell, H.; Hansson, L.; Skoog, I.; Elmfeldt, D.; Hofman, A.; Olofsson, B.; Trenkwalder, P.; Zanchetti, A. The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J. Hypertens. 2003, 21, 875-886.
-
(2003)
J. Hypertens
, vol.21
, pp. 875-886
-
-
Lithell, H.1
Hansson, L.2
Skoog, I.3
Elmfeldt, D.4
Hofman, A.5
Olofsson, B.6
Trenkwalder, P.7
Zanchetti, A.8
-
68
-
-
9144232220
-
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods
-
Fukui, T.; Rahman, M.; Hayashi, K.; Takeda, K.; Higaki, J.; Sato, T.; Fukushima, M.; Sakamoto, J.; Morita, S.; Ogihara, T. et al. Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods. Hypertens. Res. 2003, 26, 979-990.
-
(2003)
Hypertens. Res
, vol.26
, pp. 979-990
-
-
Fukui, T.1
Rahman, M.2
Hayashi, K.3
Takeda, K.4
Higaki, J.5
Sato, T.6
Fukushima, M.7
Sakamoto, J.8
Morita, S.9
Ogihara, T.10
-
69
-
-
21244435994
-
Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients
-
Suzuki, H.; Kanno, Y. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res. 2005, 28, 307-314.
-
(2005)
Hypertens Res
, vol.28
, pp. 307-314
-
-
Suzuki, H.1
Kanno, Y.2
-
70
-
-
79952103780
-
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial
-
Sandset, E.C.; Bath, P.M.; Boysen, G.; Jatuzis, D.; Korv, J.; Luders, S.; Murray, G.D.; Richter, P.S.; Roine, R.O.; Terent, A. et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial. Lancet 2011, 377, 741-750.
-
(2011)
Lancet
, vol.377
, pp. 741-750
-
-
Sandset, E.C.1
Bath, P.M.2
Boysen, G.3
Jatuzis, D.4
Korv, J.5
Luders, S.6
Murray, G.D.7
Richter, P.S.8
Roine, R.O.9
Terent, A.10
-
71
-
-
84883467305
-
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: A population-based cohort study
-
Antoniou, T.; Camacho, X.; Yao, Z.; Gomes, T.; Juurlink, D.N.; Mamdani, M.M. Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: A population-based cohort study. CMAJ 2013, 185, 1035-1041.
-
(2013)
CMAJ
, vol.185
, pp. 1035-1041
-
-
Antoniou, T.1
Camacho, X.2
Yao, Z.3
Gomes, T.4
Juurlink, D.N.5
Mamdani, M.M.6
-
72
-
-
84865822723
-
Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature
-
Carnevale, D.; Mascio, G.; D'Andrea, I.; Fardella, V.; Bell, R.D.; Branchi, I.; Pallante, F.; Zlokovic, B.; Yan, S.S.; Lembo, G. Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension 2012, 60, 188-197.
-
(2012)
Hypertension
, vol.60
, pp. 188-197
-
-
Carnevale, D.1
Mascio, G.2
D'Andrea, I.3
Fardella, V.4
Bell, R.D.5
Branchi, I.6
Pallante, F.7
Zlokovic, B.8
Yan, S.S.9
Lembo, G.10
-
73
-
-
24144445082
-
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
-
Geroldi, D.; Falcone, C.; Emanuele, E.; D'Angelo, A.; Calcagnino, M.; Buzzi, M.P.; Scioli, G.A.; Fogari, R. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 2005, 23, 1725-1729.
-
(2005)
J. Hypertens
, vol.23
, pp. 1725-1729
-
-
Geroldi, D.1
Falcone, C.2
Emanuele, E.3
D'Angelo, A.4
Calcagnino, M.5
Buzzi, M.P.6
Scioli, G.A.7
Fogari, R.8
-
74
-
-
59649124763
-
Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients
-
Nakamura, K.; Adachi, H.; Matsui, T.; Kurita, Y.; Takeuchi, M.; Yamagishi, S. Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients. Metabolism 2009, 58, 421-425.
-
(2009)
Metabolism
, vol.58
, pp. 421-425
-
-
Nakamura, K.1
Adachi, H.2
Matsui, T.3
Kurita, Y.4
Takeuchi, M.5
Yamagishi, S.6
-
75
-
-
27744574284
-
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
-
Nakamura, K.; Yamagishi, S.; Nakamura, Y.; Takenaka, K.; Matsui, T.; Jinnouchi, Y.; Imaizumi, T. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc. Res. 2005, 70, 137-141.
-
(2005)
Microvasc. Res
, vol.70
, pp. 137-141
-
-
Nakamura, K.1
Yamagishi, S.2
Nakamura, Y.3
Takenaka, K.4
Matsui, T.5
Jinnouchi, Y.6
Imaizumi, T.7
-
76
-
-
84855296756
-
Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension
-
Nakamura, T.; Sato, E.; Fujiwara, N.; Kawagoe, Y.; Yamada, S.; Ueda, Y.; Koide, H. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. Am. J. Med. Sci. 2012, 343, 46-51.
-
(2012)
Am. J. Med. Sci
, vol.343
, pp. 46-51
-
-
Nakamura, T.1
Sato, E.2
Fujiwara, N.3
Kawagoe, Y.4
Yamada, S.5
Ueda, Y.6
Koide, H.7
-
77
-
-
84856722119
-
Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein
-
Haraba, R.; Suica, V.I.; Uyy, E.; Ivan, L.; Antohe, F. Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell Tissue Res. 2011, 346, 361-368.
-
(2011)
Cell Tissue Res
, vol.346
, pp. 361-368
-
-
Haraba, R.1
Suica, V.I.2
Uyy, E.3
Ivan, L.4
Antohe, F.5
-
78
-
-
34548740746
-
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins
-
Santilli, F.; Bucciarelli, L.; Noto, D.; Cefalu, A.B.; Davi, V.; Ferrante, E.; Pettinella, C.; Averna, M.R.; Ciabattoni, G.; Davi, G. Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins. Free Radic. Biol. Med. 2007, 43, 1255-1262.
-
(2007)
Free Radic. Biol. Med
, vol.43
, pp. 1255-1262
-
-
Santilli, F.1
Bucciarelli, L.2
Noto, D.3
Cefalu, A.B.4
Davi, V.5
Ferrante, E.6
Pettinella, C.7
Averna, M.R.8
Ciabattoni, G.9
Davi, G.10
-
79
-
-
78649333667
-
HMGB1: The missing link between diabetes mellitus and heart failure
-
Volz, H.C.; Seidel, C.; Laohachewin, D.; Kaya, Z.; Muller, O.J.; Pleger, S.T.; Lasitschka, F.; Bianchi, M.E.; Remppis, A.; Bierhaus, A. et al. HMGB1: The missing link between diabetes mellitus and heart failure. Basic Res. Cardiol. 2010, 105, 805-820.
-
(2010)
Basic Res. Cardiol
, vol.105
, pp. 805-820
-
-
Volz, H.C.1
Seidel, C.2
Laohachewin, D.3
Kaya, Z.4
Muller, O.J.5
Pleger, S.T.6
Lasitschka, F.7
Bianchi, M.E.8
Remppis, A.9
Bierhaus, A.10
-
80
-
-
77449142258
-
Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands
-
Yao, D.; Brownlee, M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010, 59, 249-255.
-
(2010)
Diabetes
, vol.59
, pp. 249-255
-
-
Yao, D.1
Brownlee, M.2
-
81
-
-
0032007011
-
Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
-
Ichikawa, K.; Yoshinari, M.; Iwase, M.; Wakisaka, M.; Doi, Y.; Iino, K.; Yamamoto, M.; Fujishima, M. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis 1998, 136, 281-287.
-
(1998)
Atherosclerosis
, vol.136
, pp. 281-287
-
-
Ichikawa, K.1
Yoshinari, M.2
Iwase, M.3
Wakisaka, M.4
Doi, Y.5
Iino, K.6
Yamamoto, M.7
Fujishima, M.8
-
82
-
-
17144430517
-
Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury
-
Yonekura, H.; Yamamoto, Y.; Sakurai, S.; Watanabe, T.; Yamamoto, H. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J. Pharmacol. Sci. 2005, 97, 305-311.
-
(2005)
J. Pharmacol. Sci
, vol.97
, pp. 305-311
-
-
Yonekura, H.1
Yamamoto, Y.2
Sakurai, S.3
Watanabe, T.4
Yamamoto, H.5
-
83
-
-
33846701659
-
2- generation by mononuclear phagocytes in diabetes
-
2- generation by mononuclear phagocytes in diabetes. J. Leukoc. Biol. 2007, 81, 520-527.
-
(2007)
J. Leukoc. Biol
, vol.81
, pp. 520-527
-
-
Ding, Y.1
Kantarci, A.2
Hasturk, H.3
Trackman, P.C.4
Malabanan, A.5
van Dyke, T.E.6
-
84
-
-
77449091933
-
Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes
-
Xanthis, A.; Hatzitolios, A.; Fidani, S.; Befani, C.; Giannakoulas, G.; Koliakos, G. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes. Angiology 2009, 60, 772-779.
-
(2009)
Angiology
, vol.60
, pp. 772-779
-
-
Xanthis, A.1
Hatzitolios, A.2
Fidani, S.3
Befani, C.4
Giannakoulas, G.5
Koliakos, G.6
-
85
-
-
33744958085
-
Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells
-
Reddy, M.A.; Li, S.L.; Sahar, S.; Kim, Y.S.; Xu, Z.G.; Lanting, L.; Natarajan, R. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 2006, 281, 13685-13693.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 13685-13693
-
-
Reddy, M.A.1
Li, S.L.2
Sahar, S.3
Kim, Y.S.4
Xu, Z.G.5
Lanting, L.6
Natarajan, R.7
-
86
-
-
0027718105
-
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
-
Brett, J.; Schmidt, A.M.; Yan, S.D.; Zou, Y.S.; Weidman, E.; Pinsky, D.; Nowygrod, R.; Neeper, M.; Przysiecki, C.; Shaw, A. et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 1993, 143, 1699-1712.
-
(1993)
Am. J. Pathol
, vol.143
, pp. 1699-1712
-
-
Brett, J.1
Schmidt, A.M.2
Yan, S.D.3
Zou, Y.S.4
Weidman, E.5
Pinsky, D.6
Nowygrod, R.7
Neeper, M.8
Przysiecki, C.9
Shaw, A.10
-
87
-
-
7344228965
-
Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
-
Owen, W.F., Jr.; Hou, F.F.; Stuart, R.O.; Kay, J.; Boyce, J.; Chertow, G.M.; Schmidt, A.M. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int. 1998, 53, 1365-1373.
-
(1998)
Kidney Int
, vol.53
, pp. 1365-1373
-
-
Owen Jr., W.F.1
Hou, F.F.2
Stuart, R.O.3
Kay, J.4
Boyce, J.5
Chertow, G.M.6
Schmidt, A.M.7
-
88
-
-
0028834378
-
The dark side of glucose
-
Schmidt, A.M.; Yan, S.D.; Stern, D.M. The dark side of glucose. Nat. Med. 1995, 1, 1002-1004.
-
(1995)
Nat. Med
, vol.1
, pp. 1002-1004
-
-
Schmidt, A.M.1
Yan, S.D.2
Stern, D.M.3
-
89
-
-
34247540770
-
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice
-
Lewis, P.; Stefanovic, N.; Pete, J.; Calkin, A.C.; Giunti, S.; Thallas-Bonke, V.; Jandeleit-Dahm, K.A.; Allen, T.J.; Kola, I.; Cooper, M.E. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 2007, 115, 2178-2187.
-
(2007)
Circulation
, vol.115
, pp. 2178-2187
-
-
Lewis, P.1
Stefanovic, N.2
Pete, J.3
Calkin, A.C.4
Giunti, S.5
Thallas-Bonke, V.6
Jandeleit-Dahm, K.A.7
Allen, T.J.8
Kola, I.9
Cooper, M.E.10
-
90
-
-
65249153029
-
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes
-
Coughlan, M.T.; Thorburn, D.R.; Penfold, S.A.; Laskowski, A.; Harcourt, B.E.; Sourris, K.C.; Tan, A.L.; Fukami, K.; Thallas-Bonke, V.; Nawroth, P.P. et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J. Am. Soc. Nephrol. 2009, 20, 742-752.
-
(2009)
J. Am. Soc. Nephrol
, vol.20
, pp. 742-752
-
-
Coughlan, M.T.1
Thorburn, D.R.2
Penfold, S.A.3
Laskowski, A.4
Harcourt, B.E.5
Sourris, K.C.6
Tan, A.L.7
Fukami, K.8
Thallas-Bonke, V.9
Nawroth, P.P.10
-
91
-
-
84871735738
-
Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: Involvement of toll-like receptor 2
-
Monden, M.; Koyama, H.; Otsuka, Y.; Morioka, T.; Mori, K.; Shoji, T.; Mima, Y.; Motoyama, K.; Fukumoto, S.; Shioi, A. et al. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: Involvement of toll-like receptor 2. Diabetes 2013, 62, 478-489.
-
(2013)
Diabetes
, vol.62
, pp. 478-489
-
-
Monden, M.1
Koyama, H.2
Otsuka, Y.3
Morioka, T.4
Mori, K.5
Shoji, T.6
Mima, Y.7
Motoyama, K.8
Fukumoto, S.9
Shioi, A.10
-
92
-
-
0041342000
-
Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane
-
De Vriese, A.S.; Flyvbjerg, A.; Mortier, S.; Tilton, R.G.; Lameire, N.H. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J. Am. Soc. Nephrol. 2003, 14, 2109-2118.
-
(2003)
J. Am. Soc. Nephrol
, vol.14
, pp. 2109-2118
-
-
de Vriese, A.S.1
Flyvbjerg, A.2
Mortier, S.3
Tilton, R.G.4
Lameire, N.H.5
-
93
-
-
80052031457
-
Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling
-
Kato, T.; Yamashita, T.; Sekiguchi, A.; Tsuneda, T.; Sagara, K.; Takamura, M.; Kaneko, S.; Aizawa, T.; Fu, L.T. Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling. J. Cardiol. 2011, 58, 131-136.
-
(2011)
J. Cardiol
, vol.58
, pp. 131-136
-
-
Kato, T.1
Yamashita, T.2
Sekiguchi, A.3
Tsuneda, T.4
Sagara, K.5
Takamura, M.6
Kaneko, S.7
Aizawa, T.8
Fu, L.T.9
-
94
-
-
19944426573
-
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice
-
Fan, Q.; Liao, J.; Kobayashi, M.; Yamashita, M.; Gu, L.; Gohda, T.; Suzuki, Y.; Wang, L.N.; Horikoshi, S.; Tomino, Y. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice. Nephrol. Dial. Transplant. 2004, 19, 3012-3020.
-
(2004)
Nephrol. Dial. Transplant
, vol.19
, pp. 3012-3020
-
-
Fan, Q.1
Liao, J.2
Kobayashi, M.3
Yamashita, M.4
Gu, L.5
Gohda, T.6
Suzuki, Y.7
Wang, L.N.8
Horikoshi, S.9
Tomino, Y.10
-
95
-
-
77954692343
-
Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes
-
Ishibashi, T.; Kawaguchi, M.; Sugimoto, K.; Uekita, H.; Sakamoto, N.; Yokoyama, K.; Maruyama, Y.; Takeishi, Y. Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes. J. Atheroscler. Thromb. 2010, 17, 578-589.
-
(2010)
J. Atheroscler. Thromb
, vol.17
, pp. 578-589
-
-
Ishibashi, T.1
Kawaguchi, M.2
Sugimoto, K.3
Uekita, H.4
Sakamoto, N.5
Yokoyama, K.6
Maruyama, Y.7
Takeishi, Y.8
-
96
-
-
84871383086
-
Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients
-
Piarulli, F.; Lapolla, A.; Ragazzi, E.; Susana, A.; Sechi, A.; Nollino, L.; Cosma, C.; Fedele, D.; Sartore, G. Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients. Atherosclerosis 2012, 226, 252-257.
-
(2012)
Atherosclerosis
, vol.226
, pp. 252-257
-
-
Piarulli, F.1
Lapolla, A.2
Ragazzi, E.3
Susana, A.4
Sechi, A.5
Nollino, L.6
Cosma, C.7
Fedele, D.8
Sartore, G.9
-
97
-
-
84862923026
-
Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes
-
Su, X.D.; Li, S.S.; Tian, Y.Q.; Zhang, Z.Y.; Zhang, G.Z.; Wang, L.X. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes. Arch. Med. Res. 2011, 42, 596-601.
-
(2011)
Arch. Med. Res
, vol.42
, pp. 596-601
-
-
Su, X.D.1
Li, S.S.2
Tian, Y.Q.3
Zhang, Z.Y.4
Zhang, G.Z.5
Wang, L.X.6
-
98
-
-
0041315638
-
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control
-
Cipollone, F.; Iezzi, A.; Fazia, M.; Zucchelli, M.; Pini, B.; Cuccurullo, C.; De Cesare, D.; de Blasis, G.; Muraro, R.; Bei, R. et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control. Circulation 2003, 108, 1070-1077.
-
(2003)
Circulation
, vol.108
, pp. 1070-1077
-
-
Cipollone, F.1
Iezzi, A.2
Fazia, M.3
Zucchelli, M.4
Pini, B.5
Cuccurullo, C.6
de Cesare, D.7
de Blasis, G.8
Muraro, R.9
Bei, R.10
-
99
-
-
33751171940
-
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes
-
Cuccurullo, C.; Iezzi, A.; Fazia, M.L.; de Cesare, D.; di Francesco, A.; Muraro, R.; Bei, R.; Ucchino, S.; Spigonardo, F.; Chiarelli, F. et al. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2716-2723.
-
(2006)
Arterioscler. Thromb. Vasc. Biol
, vol.26
, pp. 2716-2723
-
-
Cuccurullo, C.1
Iezzi, A.2
Fazia, M.L.3
de Cesare, D.4
di Francesco, A.5
Muraro, R.6
Bei, R.7
Ucchino, S.8
Spigonardo, F.9
Chiarelli, F.10
-
100
-
-
34447331279
-
Soluble RAGE in type 2 diabetes: Association with oxidative stress
-
Devangelio, E.; Santilli, F.; Formoso, G.; Ferroni, P.; Bucciarelli, L.; Michetti, N.; Clissa, C.; Ciabattoni, G.; Consoli, A.; Davi, G. Soluble RAGE in type 2 diabetes: Association with oxidative stress. Free Radic. Biol. Med. 2007, 43, 511-518.
-
(2007)
Free Radic. Biol. Med
, vol.43
, pp. 511-518
-
-
Devangelio, E.1
Santilli, F.2
Formoso, G.3
Ferroni, P.4
Bucciarelli, L.5
Michetti, N.6
Clissa, C.7
Ciabattoni, G.8
Consoli, A.9
Davi, G.10
-
101
-
-
70349525016
-
Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes
-
Lu, L.; Pu, L.J.; Zhang, Q.; Wang, L.J.; Kang, S.; Zhang, R.Y.; Chen, Q.J.; Wang, J.G.; de Caterina, R.; Shen, W.F. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis 2009, 206, 540-545.
-
(2009)
Atherosclerosis
, vol.206
, pp. 540-545
-
-
Lu, L.1
Pu, L.J.2
Zhang, Q.3
Wang, L.J.4
Kang, S.5
Zhang, R.Y.6
Chen, Q.J.7
Wang, J.G.8
de Caterina, R.9
Shen, W.F.10
-
102
-
-
78650853295
-
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
-
Tam, X.H.; Shiu, S.W.; Leng, L.; Bucala, R.; Betteridge, D.J.; Tan, K.C. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes. Clin. Sci. 2011, 120, 81-89.
-
(2011)
Clin. Sci
, vol.120
, pp. 81-89
-
-
Tam, X.H.1
Shiu, S.W.2
Leng, L.3
Bucala, R.4
Betteridge, D.J.5
Tan, K.C.6
-
103
-
-
33747122292
-
Modulation of RAGE expression influences the adhesion of red blood cells from diabetic patients
-
Wautier, M.P.; Khodabandehlou, T.; Le Devehat, C.; Wautier, J.L. Modulation of RAGE expression influences the adhesion of red blood cells from diabetic patients. Clin. Hemorheol. Microcirc. 2006, 35, 379-386.
-
(2006)
Clin. Hemorheol. Microcirc
, vol.35
, pp. 379-386
-
-
Wautier, M.P.1
Khodabandehlou, T.2
Le Devehat, C.3
Wautier, J.L.4
-
104
-
-
34250675234
-
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes
-
Nakamura, K.; Yamagishi, S.; Adachi, H.; Kurita-Nakamura, Y.; Matsui, T.; Yoshida, T.; Imaizumi, T. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol. Med. 2007, 13, 185-189.
-
(2007)
Mol. Med
, vol.13
, pp. 185-189
-
-
Nakamura, K.1
Yamagishi, S.2
Adachi, H.3
Kurita-Nakamura, Y.4
Matsui, T.5
Yoshida, T.6
Imaizumi, T.7
-
105
-
-
51749123983
-
Severity of diabetic microvascular complications is associated with a low soluble RAGE level
-
Grossin, N.; Wautier, M.P.; Meas, T.; Guillausseau, P.J.; Massin, P.; Wautier, J.L. Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes Metab. 2008, 34, 392-395.
-
(2008)
Diabetes Metab
, vol.34
, pp. 392-395
-
-
Grossin, N.1
Wautier, M.P.2
Meas, T.3
Guillausseau, P.J.4
Massin, P.5
Wautier, J.L.6
-
106
-
-
32844466467
-
Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: Its possible association with diabetic vascular complications
-
Katakami, N.; Matsuhisa, M.; Kaneto, H.; Matsuoka, T.A.; Sakamoto, K.; Nakatani, Y.; Ohtoshi, K.; Hayaishi-Okano, R.; Kosugi, K.; Hori, M. et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: Its possible association with diabetic vascular complications. Diabetes Care 2005, 28, 2716-2721.
-
(2005)
Diabetes Care
, vol.28
, pp. 2716-2721
-
-
Katakami, N.1
Matsuhisa, M.2
Kaneto, H.3
Matsuoka, T.A.4
Sakamoto, K.5
Nakatani, Y.6
Ohtoshi, K.7
Hayaishi-Okano, R.8
Kosugi, K.9
Hori, M.10
-
107
-
-
33947408459
-
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
-
Tan, K.C.; Shiu, S.W.; Chow, W.S.; Leng, L.; Bucala, R.; Betteridge, D.J. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006, 49, 2756-2762.
-
(2006)
Diabetologia
, vol.49
, pp. 2756-2762
-
-
Tan, K.C.1
Shiu, S.W.2
Chow, W.S.3
Leng, L.4
Bucala, R.5
Betteridge, D.J.6
-
108
-
-
84862823013
-
A meta-analysis of receptor for advanced glycation end products gene: Four well-evaluated polymorphisms with diabetes mellitus
-
Niu, W.; Qi, Y.; Wu, Z.; Liu, Y.; Zhu, D.; Jin, W. A meta-analysis of receptor for advanced glycation end products gene: Four well-evaluated polymorphisms with diabetes mellitus. Mol. Cell Endocrinol. 2012, 358, 9-17.
-
(2012)
Mol. Cell Endocrinol
, vol.358
, pp. 9-17
-
-
Niu, W.1
Qi, Y.2
Wu, Z.3
Liu, Y.4
Zhu, D.5
Jin, W.6
-
109
-
-
80053305598
-
sRAGE in diabetic and non-diabetic critically ill patients: Effects of intensive insulin therapy
-
Arabi, Y.M.; Dehbi, M.; Rishu, A.H.; Baturcam, E.; Kahoul, S.H.; Brits, R.J.; Naidu, B.; Bouchama, A. sRAGE in diabetic and non-diabetic critically ill patients: Effects of intensive insulin therapy. Crit. Care 2011, 15, R203.
-
(2011)
Crit. Care
, vol.15
-
-
Arabi, Y.M.1
Dehbi, M.2
Rishu, A.H.3
Baturcam, E.4
Kahoul, S.H.5
Brits, R.J.6
Naidu, B.7
Bouchama, A.8
-
110
-
-
84861460150
-
Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus
-
Skrha, J., Jr.; Kalousova, M.; Svarcova, J.; Muravska, A.; Kvasnicka, J.; Landova, L.; Zima, T.; Skrha, J. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 2012, 120, 277-281.
-
(2012)
Exp. Clin. Endocrinol. Diabetes
, vol.120
, pp. 277-281
-
-
Skrha Jr., J.1
Kalousova, M.2
Svarcova, J.3
Muravska, A.4
Kvasnicka, J.5
Landova, L.6
Zima, T.7
Skrha, J.8
-
111
-
-
67650234127
-
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
-
Yan, X.X.; Lu, L.; Peng, W.H.; Wang, L.J.; Zhang, Q.; Zhang, R.Y.; Chen, Q.J.; Shen, W.F. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009, 205, 544-548.
-
(2009)
Atherosclerosis
, vol.205
, pp. 544-548
-
-
Yan, X.X.1
Lu, L.2
Peng, W.H.3
Wang, L.J.4
Zhang, Q.5
Zhang, R.Y.6
Chen, Q.J.7
Shen, W.F.8
-
112
-
-
84866080667
-
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12 year follow-up study
-
Nin, J.W.; Ferreira, I.; Schalkwijk, C.G.; Jorsal, A.; Prins, M.H.; Parving, H.H.; Tarnow, L.; Rossing, P.; Stehouwer, C.D. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12 year follow-up study. Diabetologia 2012, 55, 2489-2493.
-
(2012)
Diabetologia
, vol.55
, pp. 2489-2493
-
-
Nin, J.W.1
Ferreira, I.2
Schalkwijk, C.G.3
Jorsal, A.4
Prins, M.H.5
Parving, H.H.6
Tarnow, L.7
Rossing, P.8
Stehouwer, C.D.9
-
113
-
-
84858249608
-
ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells
-
Hu, P.; Lai, D.; Lu, P.; Gao, J.; He, H. ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int. J. Mol. Med. 2012, 29, 613-618.
-
(2012)
Int. J. Mol. Med
, vol.29
, pp. 613-618
-
-
Hu, P.1
Lai, D.2
Lu, P.3
Gao, J.4
He, H.5
-
114
-
-
84873864396
-
Ca3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells
-
Ca3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells. Lab. Invest. 2013, 93, 159-167.
-
(2013)
Lab. Invest
, vol.93
, pp. 159-167
-
-
Zhao, L.M.1
Su, X.L.2
Wang, Y.3
Li, G.R.4
Deng, X.L.5
-
115
-
-
84856597896
-
Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line
-
Hayakawa, E.; Yoshimoto, T.; Sekizawa, N.; Sugiyama, T.; Hirata, Y. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line. J. Atheroscler. Thromb. 2012, 19, 13-22.
-
(2012)
J. Atheroscler. Thromb
, vol.19
, pp. 13-22
-
-
Hayakawa, E.1
Yoshimoto, T.2
Sekizawa, N.3
Sugiyama, T.4
Hirata, Y.5
-
116
-
-
51449089179
-
Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation
-
Yamagishi, S.; Matsui, T.; Nakamura, K.; Takeuchi, M.; Inoue, H. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation. Protein. Pept. Lett. 2008, 15, 850-853.
-
(2008)
Protein. Pept. Lett
, vol.15
, pp. 850-853
-
-
Yamagishi, S.1
Matsui, T.2
Nakamura, K.3
Takeuchi, M.4
Inoue, H.5
-
117
-
-
33749052105
-
Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells
-
Fujita, M.; Okuda, H.; Tsukamoto, O.; Asano, Y.; Hirata, Y.L.; Kim, J.; Miyatsuka, T.; Takashima, S.; Minamino, T.; Tomoike, H. et al. Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26, e138-e142.
-
(2006)
Arterioscler. Thromb. Vasc. Biol
, vol.26
-
-
Fujita, M.1
Okuda, H.2
Tsukamoto, O.3
Asano, Y.4
Hirata, Y.L.5
Kim, J.6
Miyatsuka, T.7
Takashima, S.8
Minamino, T.9
Tomoike, H.10
-
118
-
-
73449133329
-
AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways
-
Liu, Y.; Liang, C.; Liu, X.; Liao, B.; Pan, X.; Ren, Y.; Fan, M.; Li, M.; He, Z.; Wu, J. et al. AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways. Atherosclerosis 2010, 208, 34-42.
-
(2010)
Atherosclerosis
, vol.208
, pp. 34-42
-
-
Liu, Y.1
Liang, C.2
Liu, X.3
Liao, B.4
Pan, X.5
Ren, Y.6
Fan, M.7
Li, M.8
He, Z.9
Wu, J.10
-
119
-
-
84862802237
-
Advanced glycation end-product Nepsilon-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes
-
Wang, Z.; Jiang, Y.; Liu, N.; Ren, L.; Zhu, Y.; An, Y.; Chen, D. Advanced glycation end-product Nepsilon-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis 2012, 221, 387-396.
-
(2012)
Atherosclerosis
, vol.221
, pp. 387-396
-
-
Wang, Z.1
Jiang, Y.2
Liu, N.3
Ren, L.4
Zhu, Y.5
An, Y.6
Chen, D.7
-
120
-
-
84861348368
-
RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity
-
Yu, W.; Liu-Bryan, R.; Stevens, S.; Damanahalli, J.K.; Terkeltaub, R. RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity. Atherosclerosis 2012, 222, 417-425.
-
(2012)
Atherosclerosis
, vol.222
, pp. 417-425
-
-
Yu, W.1
Liu-Bryan, R.2
Stevens, S.3
Damanahalli, J.K.4
Terkeltaub, R.5
-
121
-
-
52749084063
-
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
-
Soro-Paavonen, A.; Watson, A.M.; Li, J.; Paavonen, K.; Koitka, A.; Calkin, A.C.; Barit, D.; Coughlan, M.T.; Drew, B.G.; Lancaster, G.I. et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57, 2461-2469.
-
(2008)
Diabetes
, vol.57
, pp. 2461-2469
-
-
Soro-Paavonen, A.1
Watson, A.M.2
Li, J.3
Paavonen, K.4
Koitka, A.5
Calkin, A.C.6
Barit, D.7
Coughlan, M.T.8
Drew, B.G.9
Lancaster, G.I.10
-
122
-
-
80053924397
-
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression
-
Morris-Rosenfeld, S.; Blessing, E.; Preusch, M.R.; Albrecht, C.; Bierhaus, A.; Andrassy, M.; Nawroth, P.P.; Rosenfeld, M.E.; Katus, H.A.; Bea, F. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Eur. J. Clin. Invest. 2011, 41, 1164-1171.
-
(2011)
Eur. J. Clin. Invest
, vol.41
, pp. 1164-1171
-
-
Morris-Rosenfeld, S.1
Blessing, E.2
Preusch, M.R.3
Albrecht, C.4
Bierhaus, A.5
Andrassy, M.6
Nawroth, P.P.7
Rosenfeld, M.E.8
Katus, H.A.9
Bea, F.10
-
123
-
-
0000352972
-
Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes
-
Wendt, T.; Bucciarelli, L.; Qu, W.; Lu, Y.; Yan, S.F.; Stern, D.M.; Schmidt, A.M. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler. Rep. 2002, 4, 228-237.
-
(2002)
Curr Atheroscler. Rep
, vol.4
, pp. 228-237
-
-
Wendt, T.1
Bucciarelli, L.2
Qu, W.3
Lu, Y.4
Yan, S.F.5
Stern, D.M.6
Schmidt, A.M.7
-
124
-
-
79551472972
-
High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice
-
Kanellakis, P.; Agrotis, A.; Kyaw, T.S.; Koulis, C.; Ahrens, I.; Mori, S.; Takahashi, H.K.; Liu, K.; Peter, K.; Nishibori, M. et al. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 313-319.
-
(2011)
Arterioscler. Thromb. Vasc. Biol
, vol.31
, pp. 313-319
-
-
Kanellakis, P.1
Agrotis, A.2
Kyaw, T.S.3
Koulis, C.4
Ahrens, I.5
Mori, S.6
Takahashi, H.K.7
Liu, K.8
Peter, K.9
Nishibori, M.10
-
125
-
-
49249128044
-
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
-
Calkin, A.C.; Giunti, S.; Sheehy, K.J.; Chew, C.; Boolell, V.; Rajaram, Y.S.; Cooper, M.E.; Jandeleit-Dahm, K.A. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia 2008, 51, 1731-1740.
-
(2008)
Diabetologia
, vol.51
, pp. 1731-1740
-
-
Calkin, A.C.1
Giunti, S.2
Sheehy, K.J.3
Chew, C.4
Boolell, V.5
Rajaram, Y.S.6
Cooper, M.E.7
Jandeleit-Dahm, K.A.8
-
126
-
-
10644254917
-
Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: Role of activated macrophages and cytokines
-
Kalinina, N.; Agrotis, A.; Antropova, Y.; DiVitto, G.; Kanellakis, P.; Kostolias, G.; Ilyinskaya, O.; Tararak, E.; Bobik, A. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: Role of activated macrophages and cytokines. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 2320-2325.
-
(2004)
Arterioscler. Thromb. Vasc. Biol
, vol.24
, pp. 2320-2325
-
-
Kalinina, N.1
Agrotis, A.2
Antropova, Y.3
Divitto, G.4
Kanellakis, P.5
Kostolias, G.6
Ilyinskaya, O.7
Tararak, E.8
Bobik, A.9
-
127
-
-
34248342982
-
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
-
Inoue, K.; Kawahara, K.; Biswas, K.K.; Ando, K.; Mitsudo, K.; Nobuyoshi, M.; Maruyama, I. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc. Pathol. 2007, 16, 136-143.
-
(2007)
Cardiovasc. Pathol
, vol.16
, pp. 136-143
-
-
Inoue, K.1
Kawahara, K.2
Biswas, K.K.3
Ando, K.4
Mitsudo, K.5
Nobuyoshi, M.6
Maruyama, I.7
-
128
-
-
33644808985
-
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
-
Koyama, H.; Shoji, T.; Yokoyama, H.; Motoyama, K.; Mori, K.; Fukumoto, S.; Emoto, M.; Shoji, T.; Tamei, H.; Matsuki, H. et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2587-2593.
-
(2005)
Arterioscler. Thromb. Vasc. Biol
, vol.25
, pp. 2587-2593
-
-
Koyama, H.1
Shoji, T.2
Yokoyama, H.3
Motoyama, K.4
Mori, K.5
Fukumoto, S.6
Emoto, M.7
Shoji, T.8
Tamei, H.9
Matsuki, H.10
-
129
-
-
61449087504
-
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
-
Katakami, N.; Matsuhisa, M.; Kaneto, H.; Matsuoka, T.A.; Sakamoto, K.; Yasuda, T.; Umayahara, Y.; Kosugi, K.; Yamasaki, Y. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis 2009, 204, 288-292.
-
(2009)
Atherosclerosis
, vol.204
, pp. 288-292
-
-
Katakami, N.1
Matsuhisa, M.2
Kaneto, H.3
Matsuoka, T.A.4
Sakamoto, K.5
Yasuda, T.6
Umayahara, Y.7
Kosugi, K.8
Yamasaki, Y.9
-
130
-
-
33845541250
-
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats
-
Ito, T.; Kawahara, K.; Nakamura, T.; Yamada, S.; Nakamura, T.; Abeyama, K.; Hashiguchi, T.; Maruyama, I. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J. Thromb. Haemost. 2007, 5, 109-116.
-
(2007)
J. Thromb. Haemost
, vol.5
, pp. 109-116
-
-
Ito, T.1
Kawahara, K.2
Nakamura, T.3
Yamada, S.4
Nakamura, T.5
Abeyama, K.6
Hashiguchi, T.7
Maruyama, I.8
-
131
-
-
52949154618
-
RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats
-
Zhai, D.X.; Kong, Q.F.; Xu, W.S.; Bai, S.S.; Peng, H.S.; Zhao, K.; Li, G.Z.; Wang, D.D.; Sun, B.; Wang, J.H. et al. RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats. Neurosci. Lett. 2008, 445, 117-121.
-
(2008)
Neurosci. Lett
, vol.445
, pp. 117-121
-
-
Zhai, D.X.1
Kong, Q.F.2
Xu, W.S.3
Bai, S.S.4
Peng, H.S.5
Zhao, K.6
Li, G.Z.7
Wang, D.D.8
Sun, B.9
Wang, J.H.10
-
132
-
-
42549124546
-
Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products
-
Chang, J.S.; Wendt, T.; Qu, W.; Kong, L.; Zou, Y.S.; Schmidt, A.M.; Yan, S.F. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ. Res. 2008, 102, 905-913.
-
(2008)
Circ. Res
, vol.102
, pp. 905-913
-
-
Chang, J.S.1
Wendt, T.2
Qu, W.3
Kong, L.4
Zou, Y.S.5
Schmidt, A.M.6
Yan, S.F.7
-
133
-
-
67349138648
-
Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells
-
Kikuchi, K.; Kawahara, K.; Biswas, K.K.; Ito, T.; Tancharoen, S.; Morimoto, Y.; Matsuda, F.; Oyama, Y.; Takenouchi, K.; Miura, N. et al. Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem. Biophys. Res. Commun. 2009, 385, 132-136.
-
(2009)
Biochem. Biophys. Res. Commun
, vol.385
, pp. 132-136
-
-
Kikuchi, K.1
Kawahara, K.2
Biswas, K.K.3
Ito, T.4
Tancharoen, S.5
Morimoto, Y.6
Matsuda, F.7
Oyama, Y.8
Takenouchi, K.9
Miura, N.10
-
134
-
-
66749132080
-
The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells
-
Kikuchi, K.; Kawahara, K.; Tancharoen, S.; Matsuda, F.; Morimoto, Y.; Ito, T.; Biswas, K.K.; Takenouchi, K.; Miura, N.; Oyama, Y. et al. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J. Pharmacol. Exp. Ther. 2009, 329, 865-874.
-
(2009)
J. Pharmacol. Exp. Ther
, vol.329
, pp. 865-874
-
-
Kikuchi, K.1
Kawahara, K.2
Tancharoen, S.3
Matsuda, F.4
Morimoto, Y.5
Ito, T.6
Biswas, K.K.7
Takenouchi, K.8
Miura, N.9
Oyama, Y.10
-
135
-
-
80055009332
-
High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products
-
Mazarati, A.; Maroso, M.; Iori, V.; Vezzani, A.; Carli, M. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp. Neurol. 2011, 232, 143-148.
-
(2011)
Exp. Neurol
, vol.232
, pp. 143-148
-
-
Mazarati, A.1
Maroso, M.2
Iori, V.3
Vezzani, A.4
Carli, M.5
-
136
-
-
33750078962
-
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein
-
Pedrazzi, M.; Raiteri, L.; Bonanno, G.; Patrone, M.; Ledda, S.; Passalacqua, M.; Milanese, M.; Melloni, E.; Raiteri, M.; Pontremoli, S. et al. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J. Neurochem. 2006, 99, 827-838.
-
(2006)
J. Neurochem
, vol.99
, pp. 827-838
-
-
Pedrazzi, M.1
Raiteri, L.2
Bonanno, G.3
Patrone, M.4
Ledda, S.5
Passalacqua, M.6
Milanese, M.7
Melloni, E.8
Raiteri, M.9
Pontremoli, S.10
-
137
-
-
37549011413
-
Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia
-
Pichiule, P.; Chavez, J.C.; Schmidt, A.M.; Vannucci, S.J. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J.Biol. Chem. 2007, 282, 36330-36340.
-
(2007)
J.Biol. Chem
, vol.282
, pp. 36330-36340
-
-
Pichiule, P.1
Chavez, J.C.2
Schmidt, A.M.3
Vannucci, S.J.4
-
138
-
-
84856281473
-
RAGE mediates vascular injury and inflammation after global cerebral ischemia
-
Kamide, T.; Kitao, Y.; Takeichi, T.; Okada, A.; Mohri, H.; Schmidt, A.M.; Kawano, T.; Munesue, S.; Yamamoto, Y.; Yamamoto, H. et al. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem. Int. 2012, 60, 220-228.
-
(2012)
Neurochem. Int
, vol.60
, pp. 220-228
-
-
Kamide, T.1
Kitao, Y.2
Takeichi, T.3
Okada, A.4
Mohri, H.5
Schmidt, A.M.6
Kawano, T.7
Munesue, S.8
Yamamoto, Y.9
Yamamoto, H.10
-
139
-
-
58149352350
-
The HMGB1 receptor RAGE mediates ischemic brain damage
-
Muhammad, S.; Barakat, W.; Stoyanov, S.; Murikinati, S.; Yang, H.; Tracey, K.J.; Bendszus, M.; Rossetti, G.; Nawroth, P.P.; Bierhaus, A. et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28, 12023-12031.
-
(2008)
J. Neurosci
, vol.28
, pp. 12023-12031
-
-
Muhammad, S.1
Barakat, W.2
Stoyanov, S.3
Murikinati, S.4
Yang, H.5
Tracey, K.J.6
Bendszus, M.7
Rossetti, G.8
Nawroth, P.P.9
Bierhaus, A.10
-
140
-
-
36849076615
-
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
-
Liu, K.; Mori, S.; Takahashi, H.K.; Tomono, Y.; Wake, H.; Kanke, T.; Sato, Y.; Hiraga, N.; Adachi, N.; Yoshino, T. et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007, 21, 3904-3916.
-
(2007)
FASEB J
, vol.21
, pp. 3904-3916
-
-
Liu, K.1
Mori, S.2
Takahashi, H.K.3
Tomono, Y.4
Wake, H.5
Kanke, T.6
Sato, Y.7
Hiraga, N.8
Adachi, N.9
Yoshino, T.10
-
141
-
-
33745788420
-
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
-
Kim, J.B.; Sig Choi, J.; Yu, Y.M.; Nam, K.; Piao, C.S.; Kim, S.W.; Lee, M.H.; Han, P.L.; Park, J.S.; Lee, J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 2006, 26, 6413-6421.
-
(2006)
J. Neurosci
, vol.26
, pp. 6413-6421
-
-
Kim, J.B.1
Sig, C.J.2
Yu, Y.M.3
Nam, K.4
Piao, C.S.5
Kim, S.W.6
Lee, M.H.7
Han, P.L.8
Park, J.S.9
Lee, J.K.10
-
142
-
-
79955473647
-
Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats
-
Zhang, J.; Takahashi, H.K.; Liu, K.; Wake, H.; Liu, R.; Maruo, T.; Date, I.; Yoshino, T.; Ohtsuka, A.; Mori, S. et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011, 42, 1420-1428.
-
(2011)
Stroke
, vol.42
, pp. 1420-1428
-
-
Zhang, J.1
Takahashi, H.K.2
Liu, K.3
Wake, H.4
Liu, R.5
Maruo, T.6
Date, I.7
Yoshino, T.8
Ohtsuka, A.9
Mori, S.10
-
143
-
-
70149105016
-
Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism
-
Haraguchi, T.; Takasaki, K.; Naito, T.; Hayakawa, K.; Katsurabayashi, S.; Mishima, K.; Iwasaki, K.; Fujiwara, M. Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Neurosci. Lett. 2009, 464, 151-155.
-
(2009)
Neurosci. Lett
, vol.464
, pp. 151-155
-
-
Haraguchi, T.1
Takasaki, K.2
Naito, T.3
Hayakawa, K.4
Katsurabayashi, S.5
Mishima, K.6
Iwasaki, K.7
Fujiwara, M.8
-
144
-
-
84883555885
-
Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke
-
Huang, J.M.; Hu, J.; Chen, N.; Hu, M.L. Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke. J. Crit. Care 2013, 28, 792-797.
-
(2013)
J. Crit. Care
, vol.28
, pp. 792-797
-
-
Huang, J.M.1
Hu, J.2
Chen, N.3
Hu, M.L.4
-
145
-
-
78349277357
-
Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage
-
2010
-
Zhou, Y.; Xiong, K.L.; Lin, S.; Zhong, Q.; Lu, F.L.; Liang, H.; Li, J.C.; Wang, J.Z.; Yang, Q.W. Elevation of high-mobility group protein box-1 in serum correlates with severity of acute intracerebral hemorrhage. Mediators Inflamm. 2010, 2010, 142458:1-142458:6.
-
(2010)
Mediators Inflamm
, pp. 1424581-1424586
-
-
Zhou, Y.1
Xiong, K.L.2
Lin, S.3
Zhong, Q.4
Lu, F.L.5
Liang, H.6
Li, J.C.7
Wang, J.Z.8
Yang, Q.W.9
-
146
-
-
70350617949
-
Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients
-
Yokota, C.; Minematsu, K.; Tomii, Y.; Naganuma, M.; Ito, A.; Nagasawa, H.; Yamaguchi, T. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients. J. Neurol. Sci. 2009, 287, 41-44.
-
(2009)
J. Neurol. Sci
, vol.287
, pp. 41-44
-
-
Yokota, C.1
Minematsu, K.2
Tomii, Y.3
Naganuma, M.4
Ito, A.5
Nagasawa, H.6
Yamaguchi, T.7
-
147
-
-
0029066877
-
Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine
-
Zimmerman, G.A.; Meistrell, M., III; Bloom, O.; Cockroft, K.M.; Bianchi, M.; Risucci, D.; Broome, J.; Farmer, P.; Cerami, A.; Vlassara, H. et al. Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proc. Natl. Acad. Sci. USA 1995, 92, 3744-3748.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 3744-3748
-
-
Zimmerman, G.A.1
Meistrell III, M.2
Bloom, O.3
Cockroft, K.M.4
Bianchi, M.5
Risucci, D.6
Broome, J.7
Farmer, P.8
Cerami, A.9
Vlassara, H.10
-
148
-
-
0033199996
-
Pathobiology of ischaemic stroke: An integrated view
-
Dirnagl, U.; Iadecola, C.; Moskowitz, M.A. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999, 22, 391-397.
-
(1999)
Trends Neurosci
, vol.22
, pp. 391-397
-
-
Dirnagl, U.1
Iadecola, C.2
Moskowitz, M.A.3
-
149
-
-
33750913676
-
Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation
-
Yoshida, T.; Yamagishi, S.; Nakamura, K.; Matsui, T.; Imaizumi, T.; Takeuchi, M.; Koga, H.; Ueno, T.; Sata, M. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia 2006, 49, 3094-3099.
-
(2006)
Diabetologia
, vol.49
, pp. 3094-3099
-
-
Yoshida, T.1
Yamagishi, S.2
Nakamura, K.3
Matsui, T.4
Imaizumi, T.5
Takeuchi, M.6
Koga, H.7
Ueno, T.8
Sata, M.9
|